General Moly, Inc.
GMO
GMO was delisted on the 30th of September, 2020.
66 hedge funds and large institutions have $22.2M invested in General Moly, Inc. in 2014 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 22 reducing their positions, and 14 closing their positions.
67% more call options, than puts
Call options by funds: $10K | Put options by funds: $6K
50% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 14
16% more capital invested
Capital invested by funds: $19.1M → $22.2M (+$3.04M)
12% more funds holding
Funds holding: 59 → 66 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
50% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
+$3.05M |
| 2 |
BPGAM
BTG Pactual Global Asset Management
Hamilton,
Bermuda
|
+$365K |
| 3 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
+$292K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$282K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$258K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.48M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.02M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$529K |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$241K |
| 5 |
Bank of New York Mellon
New York
|
-$218K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
76
Profund Advisors
Bethesda,
Maryland
| – | -$11K | -10,800 | Closed |
|
|
U
77
UBS
Zurich,
Switzerland
| – | -$6.26K | -6,000 | Closed |
|
78
Ameriprise
Minneapolis,
Minnesota
| – | +$198 | +190 | New |
|
|
TDC
79
Thompson Davis & Co
Richmond,
Virginia
| – | +$2.09K | +2,000 | New |
|
GMO Hedge Fund Activity: Q2 2014 in Review
66 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in General Moly, Inc. (GMO) for Q2 2014, worth a combined $22.2M — up 16% from $19.1M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new GMO positions and 14 closed out — a net gain of 7 holders — while 11 added to existing stakes and 22 trimmed.
The largest buyer was University of Texas/Texas AM Investment Management Co (UTIMCO), opening a new position worth an estimated $3.05M. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.48M.
- 66 institutional investors held General Moly, Inc. (GMO) as of Q2 2014, up from 59 in Q1 2014.
- Funds reported $22.2M of General Moly, Inc. stock for Q2 2014, up 16% quarter-over-quarter.
- 21 funds opened new General Moly, Inc. positions in Q2 2014 and 14 closed out, a net change of +7 holders.
- The largest General Moly, Inc. buyer in Q2 2014 was University of Texas/Texas AM Investment Management Co (UTIMCO), an estimated $3.05M added.
- The largest General Moly, Inc. seller in Q2 2014 was BlackRock Fund Advisors, an estimated $1.48M sold.
Based on aggregated 13F filings for Q2 2014.